Please use this identifier to cite or link to this item:
Title: Cannabis for medicinal purposes : legislative, regulatory and clinical implications
Authors: Mifsud Buhagiar, Luana
Vella, Kristina
Serracino-Inglott, Anthony
Gauci, Charmaine
Keywords: Cannabis -- Health aspects
Cannabis -- Therapeutic use
Cannabis -- Malta
Drug legalization -- Malta
Drug legalization -- Malta -- Public opinion
Issue Date: 2020
Publisher: University of Malta. Department of Pharmacy
Citation: Mifsud Buhagiar, L., Vella, K., Serracino-Inglott, A., & Gauci, C. (2020). Cannabis for medicinal purposes : legislative, regulatory and clinical implications. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition.
Abstract: Medicinal cannabis entails evolving dynamics, marked by considerations of therapeutic potential and safety concerns, ambivalent perceptions and scientific evidence, alongside accessibility issues tantamount to limited harmonisation across jurisdictions. Cannabis for medicinal purposes is largely regulated by provisions implemented on a State-by-State basis. The Laws of Malta were amended in 2018, enabling the prescribing of cannabis-based products manufactured under Good Manufacturing Practice (GMP). The national legislative amendments present an opportunity to assess the implications of regulatory requirements for controlled, quality medicinal cannabis products and to examine local predispositions in prescribing and clinical use.
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Cannabis for Medicinal Purposes - Legislative, Regulatory and Clinical Implications.pdf797.54 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.